New: Introducing “Why Is It Moving?” - lightning-fast, AI-driven explanations of stock moves

Daxor Corporation

Contributing Author

Recent Articles by Daxor Corporation

Oct-15	Daxor's New BVA Technology To Be Showcased At MedAxiom CV Transforum Fall '25 DXR GlobeNewswire
Sep-30	Daxor Unveils New FDA-Cleared BVA Analyzer Amid Strong Market Demand and Pivotal Clinical Data at HFSA DXR GlobeNewswire
Sep-23	Daxor Corporation Unveils Breakthrough Next-Gen BVA Analyzer at HFSA Annual Scientific Meeting DXR GlobeNewswire
Sep-04	Daxor's Blood Volume Analysis Validated for COVID and Sepsis Patients in New Peer-Reviewed Pilot Study Published in the Journal of Critical Care DXR GlobeNewswire
Sep-03	Daxor Corporation to Present at the H.C. Wainwright 27th Annual Global Investment Conference DXR GlobeNewswire
Sep-02	Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter DXR GlobeNewswire
Aug-12	Daxor Corporation Announces Replay of Nasdaq Closing Bell Ceremony Now Available DXR GlobeNewswire
Aug-07	Daxor Corporation Receives FDA Clearance for New Rapid, Lightweight, Blood Volume Analysis System DXR GlobeNewswire
Jul-22	Daxor's Blood Volume Analysis Technology Accelerates Market Penetration with Three New Facility Adoptions DXR GlobeNewswire
May-14	Daxor Announces Duke University Study on Blood Volume Analysis in Heart Failure Published in American Heart Journal DXR GlobeNewswire
May-13	Daxor's Blood Volume Analysis Diagnostic Reaches Two New U.S. Healthcare Systems DXR GlobeNewswire
May-07	Florida Healthcare Leader Embraces Daxor Blood Volume Analysis Technology DXR GlobeNewswire
May-06	Three New Medical Centers Adopt Daxor's Blood Volume Diagnostic Signaling Growing Clinical Acceptance DXR GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.